Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa

Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East and Africa (EMEA). In his role,... - July 05, 2022 - Hemanext

Don't Let Joint Pain Hold You Back

Adventist Health Simi Valley is Ventura County’s first Robotic Center of Excellence and provides the community with the latest joint-replacement techniques resulting in less pain, shorter hospital stays and quicker recoveries. - July 02, 2022 - Adventist Health

NF Sports Releases New "Immune Defense(TM)" Drink Mix

Nutrition Supplement Company Aims to Combat Weakened Immune Systems by Helping to Limit the Spread of Viruses at the Cellular Level. - June 30, 2022 - NF Sports

Foundation Supporting Indigenous Students to Return a Half-Million Dollars to a Catholic Organization

Foundation Supporting Indigenous Students to Return a Half-Million Dollars to a Catholic Organization

The Verna J. Kirkness Education Foundation Board Chair, Tony Williams, plans to announce the Board’s decision to return the $500,000 endowment to the Sisters of Saint Anne and terminate the 4.5-year-long relationship. In his announcement, Tony Williams will explain his Board’s decision... - June 24, 2022 - Verna J. Kirkness Foundation

iTech Offers 60-Day Free Trial on expEDIum Medical Billing® Product

iTech, a leading Healthcare IT Solutions vendor specializing in delivering a secure, affordable, and comprehensive cloud-based Medical Billing & Practice Management Software, offers a 60-day free trial on their expEDIum Medical Billing® product. - June 24, 2022 - iTech Workshop Private Limited

PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator

PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator

PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars

Defined Bioscience Announces Formation of Scientific Advisory Board

Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.

GENINVO Launches Its Latest Offering - Innovation as a Service

GENINVO, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Innovation as a Service. GENINVO has recognized various challenges the pharmaceutical industry faces, especially in the wake of the pandemic. The need to expedite clinical... - June 12, 2022 - GenInvo, Inc.

Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety

Creative Diagnostics introduced CC50/IC50 testing services with a high level of detection sensitivity and accuracy. - June 11, 2022 - Creative Diagnostics

Creative Diagnostics Launches Measles Virus Antigens for the Detection of Antibodies

Creative Diagnostics announced the release of new measles virus antigens suitable for both IgM and IgG detection. - June 11, 2022 - Creative Diagnostics

HealthWare Systems Expands Services

HealthWare Systems meets evolving client needs with healthcare automation solutions, RPA, and services divisions – CredentialingOne & EligibilityAdvocates. - June 10, 2022 - HealthWare Systems

PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort

PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort

PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars

Isaac Health Launches Affordable, Convenient Specialist Memory Clinic Services at Home

Isaac Health Launches Affordable, Convenient Specialist Memory Clinic Services at Home

Isaac Health is a national provider of dementia care via a virtual platform from the safety of your home. They diagnose, treat, manage, and coordinate care for you in collaboration with your physician, loved ones, and/or senior living community - June 04, 2022 - Isaac Health

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Announces Phase 2a Trial Results of Tegoprubart (AT-1501) – a Drug Invented at ALS TDI

Eledon Pharmaceuticals announced topline results from their Phase 2 trial of tegoprubart (formerly AT1501), a drug invented and developed at the ALS Therapy Development Institute (ALS TDI). The Phase 2a trial in ALS was a 12-week, open label, dose escalating, safety, and biomarker study. The... - May 31, 2022 - ALS Therapy Development Institute

UnifyTwin Launches Intelligent Industrial App Suite Addressing Industry 5.0 Transformation with Proven Business Outcomes

UnifyTwin Launches Intelligent Industrial App Suite Addressing Industry 5.0 Transformation with Proven Business Outcomes

UnifyTwin announces the launch of Intelligent Industrial App Suite that offers five Business Apps to address various aspects of the industrial life cycle driving towards sustainable business outcomes. These apps are now deployed and validated in over 450+ industrial customers worldwide in multiple industry segments such as Pharma & Chemical, Textile, Refinery & Energy, Metals & Minerals and Building Materials. UnifyTwin is now on an expansion path and is pursuing strategic partnerships. - May 31, 2022 - UnifyTwin Inc

Period Tracking App, Femometer, Launches Discount and Offers in Celebration of 10 Million Users

Reproductive, period, and pregnancy tracking app, Femometer, is celebrating a milestone of 10 million users. Femometer is offering more than half-off the Prime Membership option, as well as select products purchased through the app. The celebratory discount will be available to users from the 1st of June to 8th of June. - May 31, 2022 - Lollipop Technology Hangzhou Ltd. Co.

Scientific Reports Publishes Data Demonstrating VR Platform Produces Peak Experiences, Ego Attenuation & Connectedness Comparable to Moderate Dose Psychedelics

Scientific Reports Publishes Data Demonstrating VR Platform Produces Peak Experiences, Ego Attenuation & Connectedness Comparable to Moderate Dose Psychedelics

aNUma, Inc., a digital therapeutics company building virtual reality programs to address the global mental health crisis, today, announced that Scientific Reports has published research demonstrating technology like that behind aNUma’s VR platform can deliver peak experiences, ego attenuation, and connectedness comparable to psychedelics. This study, written by Dr. David Glowacki and colleagues, is the first of its kind to be published in a leading peer-reviewed journal. - May 30, 2022 - aNUma

Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests

Creative Diagnostics recently launched recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA). - May 26, 2022 - Creative Diagnostics

Creative Diagnostics Launches Antibody-Dependent Enhancement Assay Services

Creative Diagnostics recently introduces comprehensive services for antibody-dependent enhancement (ADE) assay. - May 26, 2022 - Creative Diagnostics

Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase

Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase

Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS CoV-2/COVID Prophylactics.” Dr. Neil Bodie, CEO of Paradigm Immunotherapeutics (“Paradigm”), will present at the Los Angeles... - May 25, 2022 - Paradigm Immunotherapeutics

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

ALS Therapy Development Institute Scientists to Present Posters Sharing Research Advancements at the ALS Drug Development Summit

The ALS TDI scientists will be showcasing significant advancements in ALS research through multiple poster presentations. These posters will cover pre-clinical research exploring potential new therapeutic drug-like molecules and targets for ALS, as well as translational research analyzing patient data to identify new ALS biomarkers, drug targets, and patient populations. - May 25, 2022 - ALS Therapy Development Institute

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program

Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners

Molekule Consulting Announces the Launch of E.U. - Based Operations

Molekule Consulting Announces the Launch of E.U. - Based Operations

Molekule Consulting announces the launch of an E.U. - based business / Molekule Hub continuing their focus on the development of global strategy and advisory services for the biopharmaceutical sector. - May 24, 2022 - Molekule Consulting

Baltimore Innovation Invited You to Come and Meet Them for Coffee

Baltimore Innovations staff was present at Pharmapack in Paris on the 18 May 2022. This show is a popular event for the pharmaceutical packaging industry, and a great way to get new ideas from all over the world. Baltimore Innovations’ Global Sales Director Philippe Depois was in attendance... - May 24, 2022 - Baltimore Innovation

ASAcampus Involved Once Again in an Experiment That Will Take Place on the International Space Station

The experiment, selected by the European Space Agency in the ESA-ILSRA2014 call and with the support of the Italian Space Agency (C-ASI N. 2018-14-U.0-Suture in Space), aims to study the process of surgical wound healing in space. - May 22, 2022 - ASA srl

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology

Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology

LifeBiotic's Botanical Formula Shows Significant Destruction of Multiple GI Cancer Cells

In a new cell model study, the patented LCS101 formula eliminated up to 90% of cancer cells within 72 hours. - May 19, 2022 - Lifebiotic

NuvOx Pharma Announces Issuance of a New Patent

NuvOx Pharma has been issued US Patent No. 11,304,899, entitled “Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof.” - May 19, 2022 - NuvOx Pharma

M&M Labs President and CEO Launches WellRabbit, a Physician-Vetted Supplement Website That Promotes Health and Wellness

The President and CEO of South Carolina and North Carolina-based M&M Labs, a physician-driven company that formulates, manufactures, and distributes nutraceutical products, is announcing the launch of a new supplement website. Dr. Jeffrey Hendricks is one of four founders of WellRabbit, an... - May 16, 2022 - WellRabbit

Intrinsica Announces Innovation Acceleration Forum for Solving $528 Billion Dollar Medications Use Challenge

Intrinsica Announces Innovation Acceleration Forum for Solving $528 Billion Dollar Medications Use Challenge

Today, Intrinsica Inc., a non-profit organization, announced the dates for the RAPID Alliance 2.0 Launch Meeting and Innovation Acceleration Forum for solving a $528 billion dollar medications use challenge affecting 200 million or more people in the US. The event is occurring on June 21 and 22, 2022, virtually. The event is designed to bring together a select group of leaders, scholars, innovators, funders, technologists, government leaders and others from across the US medications sector. - May 13, 2022 - Intrinsica, Inc.

NuvOx Appoints Dr. Robert King to SAB

NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, appointed Dr. Robert King to its Scientific Advisory Board (SAB). Dr. King is a seasoned life science executive with over 30 years’... - May 11, 2022 - NuvOx Pharma

CMR Institute's Board of Directors Welcomes New Board Member

CMR Institute's Board of Directors recently held their annual meeting and selected new leadership, along with voting in a new board member, Andrew Krumerman, MD. Andrew Krumerman, MD, is an Attending Physician in the Division of Cardiology and Division of Cardiac Electrophysiology at Montefiore,... - May 10, 2022 - CMR Institute

Cmr Institute's Board of Directors Vote on New Chairman, Vice Chair

CMR Institute's Board of Directors recently held their annual meeting and selected new leadership, electing Dr. Jeffrey Farber as Chairman of the Board and Dr. Mark Sorrentino as the Vice-Chair. Jeffrey Farber, MD, MBA, FACP, a board-certified geriatrician and internist, is the President and CEO... - May 10, 2022 - CMR Institute

Terrain Health Expands, Offering Innovative Solutions to Patients in Direct Patient Care and in Natural and Effective Fertility Solutions

Terrain Health, an international, precision healthcare organization focusing on integrative and functional medicine utilizing next generation healthcare tools, is pleased to announce they are expanding their practice to best meet the needs of its patients. Terrain Health is now offering Direct... - May 09, 2022 - Terrain Health Inc.

The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS

The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS

The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022 - ALS Therapy Development Institute

Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek

Cyclists Support ALS Research with 3-Day, 270-Mile Ride from Boston to Greenwich in Tri-State Trek

Hundreds of riders to join the ride to end ALS this June and raise funds for cutting-edge ALS research. ALS TDI has received a $100,000 match for all donations made to the Tri-State Trek through the month of May. - May 03, 2022 - ALS Therapy Development Institute

Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies

Creative Diagnostics recently launches a series of NiV recombinant antigen and antibody pairs. - April 30, 2022 - Creative Diagnostics

“Fight ALS Film Fest” Aims to Shine a Spotlight on the World of ALS

Films explore universal themes of life-changing diseases through examination of ALS. Films and dialogue aim to improve understanding, uplift those affected, and expand the community. - April 25, 2022 - ALS Therapy Development Institute

BioSource Celebrating 25 Years in Business

This May marks 25 years since the start of BioSource Cultures & Flavors Inc. Support, guidance, and friendship of customers have made this milestone possible. Since 1997, BioSource has grown organically, as a family business started by Dr. Narayan Suresh and his wife Archana Suresh as... - April 23, 2022 - BioSource Cultures and Flavors

American Laboratory Products Company Merges with GeneProof

American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination creates a global market leader... - April 21, 2022 - ALPCO

Microvascular Therapeutics Finalizes Facility Certification for the Production of Its Product, MVT-100

Microvascular Therapeutics (MVT), a clinical stage biotechnology company, finalized its manufacturing facility certifications for the GMP production of its first product, MVT-100. - April 21, 2022 - Microvascular Therapeutics

NuvOx Technology Featured in Prominent Peer Review Journal

NuvOx Pharma’s technology, which is developed as a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, was featured in the prominent journal of Frontiers of Neurology. - April 19, 2022 - NuvOx Pharma

NuvOx Finalizes Facility Certification, Poising for Phase IIb Trials

NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role, finalized its manufacturing facility certifications for Phase IIb trials. - April 17, 2022 - NuvOx Pharma

River Valley Relief Launches Relief by RVR Line of Marijuana Concentrates

River Valley Relief Launches Relief by RVR Line of Marijuana Concentrates

Arkansas has always been a state known for finding diamonds; just maybe not the kind that are coming out of Fort Smith recently. River Valley Relief Cultivation (“RVR”) has been hard at work producing live diamonds, among other live resin extracts, that were released to many Arkansas... - April 15, 2022 - River Valley Relief

Adventist Health Simi Valley and Moorpark Community College Have Entered Into an Exclusive Multi-Year Partnership

Adventist Health Simi Valley is going directly into the community to provide care outside the walls of the hospital. - April 13, 2022 - Adventist Health

Dr. Claudia C. Cotca of C3 Think Tank Appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health

Dr. Claudia C. Cotca of C3 Think Tank appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health. Together with leadership and military health experts, stakeholders and program officers, Dr. Claudia C Cotca will help support and contribute to the scope and mission of ATARC’s Warfighter Health in incorporating responsibly artificial intelligence in military medicine. - April 13, 2022 - C3 Think Tank

Biolexis Therapeutics Announces Poster Presentation at AACR 2022 Annual Meeting

Biolexis Therapeutics Inc., a leader in bio-tech research and creator of the FIELDS™ process, today announced that data highlighting an orally available, CDK9 selective small molecule inhibitor showing promise in n-Myc-driven neuroendocrine prostate cancers (NEPC) was presented in a poster at... - April 11, 2022 - Biolexis Therapeutics Inc.

CredentialingOne – New Credentialing Outsourcing Company Powered by HealthWare Systems

The credentialing outsourcing company CredentialingOne combines HealthWare Systems automation technology with the expertise of Credentialing Specialists. - April 10, 2022 - HealthWare Systems

Degree Controls Integrates Airflow Monitors and Calibrated Anemometers

Degree Controls integrates airflow monitors and calibrated anemometers for fume hood certification using automated entry of face velocity measurements. - April 09, 2022 - Degree Controls

Microvascular Therapeutics Receives Funds from Commercialization Readiness Program for the Development of Its Ultrasound Contrast Agent, MVT-100

MicrovMicrovascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a Commercialization Readiness Program grant from the National Institute of Heart, Lung, and Blood Institute (NHLBI). Wyatt Unger, MD, MBA, Chief Medical Officer of MVT said, “We are... - April 09, 2022 - Microvascular Therapeutics

Press Releases 1 - 50 of 8,256